[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$ttiv](/topic/$ttiv) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Large-cap pharmas renewed buying spree in metabolic and genetic disease continues with Novo Nordisks $5.2B acquisition of $AKRO underscoring surging interest in MASH and mitochondrial-linked disorders. $TTI.v $TTIPF Notably $AKRO's EFX targets mechanisms tied to oxidative stress similar to @thiogenesis's cysteamine-based platform addressing oxidative and mitochondrial dysfunction across rare and metabolic diseases. With three Phase X programs in MELAS Leigh Syndrome and pediatric MASH $TTI offers diversified exposure to these fast-moving therapeutic areas. Backed by extended IP through 2038" [X Link](https://x.com/StckMasterFlash/status/1978583822028730847) [@StckMasterFlash](/creator/x/StckMasterFlash) 2025-10-15T22:08Z 3026 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Large-cap pharmas renewed buying spree in metabolic and genetic disease continues with Novo Nordisks $5.2B acquisition of $AKRO underscoring surging interest in MASH and mitochondrial-linked disorders. $TTI.v $TTIPF Notably $AKRO's EFX targets mechanisms tied to oxidative stress similar to @thiogenesis's cysteamine-based platform addressing oxidative and mitochondrial dysfunction across rare and metabolic diseases. With three Phase X programs in MELAS Leigh Syndrome and pediatric MASH $TTI offers diversified exposure to these fast-moving therapeutic areas. Backed by extended IP through 2038"
X Link @StckMasterFlash 2025-10-15T22:08Z 3026 followers, XXX engagements
/topic/$ttiv/posts